Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuyasu Fujii

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Acta Medica Okayama|November 24, 2004
A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infectionsKeiji Iwatsuki, Takenobu Yamamoto, Kazuhide Tsuji, et al.
Proteomics|September 8, 2004
Proteomic signature of human cancer cellsMasahiro Seike, Tadashi Kondo, Kazuyasu Fujii, et al.
Journal of Dermatological Science|February 3, 2021
Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphomaNozomi Jimura, Kazuyasu Fujii, Zhiwei Qiao, et al.
Journal of Dermatological Science|February 4, 2018
HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitorsKazuyasu Fujii, Norihiro Suzuki, Nozomi Jimura, et al.
The Journal of Dermatology|February 13, 2018
Ethosuximide-induced Stevens-Johnson syndrome: Beneficial effect of early intervention with high-dose corticosteroid therapyKota Tachibana, Toshihisa Hamada, Hiroki Tsuchiya, et al.
The Journal of Dermatology|April 6, 2007
Prospective study of clinical symptoms and skin test reactions in medical students exposed to formaldehyde gasSachiko Takahashi, Kazuhide Tsuji, Kazuyasu Fujii, et al.
Journal of Proteomics|November 30, 2011
Proteomic study identified HSP 70 kDa protein 1A as a possible therapeutic target, in combination with histone deacetylase inhibitors, for lymphoid neoplasmsKazuyasu Fujii, Norihiro Suzuki, Kazuko Ikeda, et al.
Journal of Dermatological Science|February 9, 2020
Cutaneous lymphoma in Japan, 2012-2017: A nationwide studyKazuyasu Fujii, Toshihisa Hamada, Takatoshi Shimauchi, et al.
Immunopharmacology and Immunotoxicology|April 5, 2005
Effect of formaldehyde gas exposure in a murine allergic contact hypersensitivity modelKazuyasu Fujii, Kazuhide Tsuji, Hironori Matsuura, et al.
The Journal of Clinical Investigation|September 8, 2007
Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomasMirjana Urosevic, Kazuyasu Fujii, Bastien Calmels, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Acta Medica Okayama|November 24, 2004
A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infectionsKeiji Iwatsuki, Takenobu Yamamoto, Kazuhide Tsuji, et al.
Proteomics|September 8, 2004
Proteomic signature of human cancer cellsMasahiro Seike, Tadashi Kondo, Kazuyasu Fujii, et al.
Journal of Dermatological Science|February 3, 2021
Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphomaNozomi Jimura, Kazuyasu Fujii, Zhiwei Qiao, et al.
Journal of Dermatological Science|February 4, 2018
HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitorsKazuyasu Fujii, Norihiro Suzuki, Nozomi Jimura, et al.
The Journal of Dermatology|February 13, 2018
Ethosuximide-induced Stevens-Johnson syndrome: Beneficial effect of early intervention with high-dose corticosteroid therapyKota Tachibana, Toshihisa Hamada, Hiroki Tsuchiya, et al.
The Journal of Dermatology|April 6, 2007
Prospective study of clinical symptoms and skin test reactions in medical students exposed to formaldehyde gasSachiko Takahashi, Kazuhide Tsuji, Kazuyasu Fujii, et al.
Journal of Proteomics|November 30, 2011
Proteomic study identified HSP 70 kDa protein 1A as a possible therapeutic target, in combination with histone deacetylase inhibitors, for lymphoid neoplasmsKazuyasu Fujii, Norihiro Suzuki, Kazuko Ikeda, et al.
Journal of Dermatological Science|February 9, 2020
Cutaneous lymphoma in Japan, 2012-2017: A nationwide studyKazuyasu Fujii, Toshihisa Hamada, Takatoshi Shimauchi, et al.
Immunopharmacology and Immunotoxicology|April 5, 2005
Effect of formaldehyde gas exposure in a murine allergic contact hypersensitivity modelKazuyasu Fujii, Kazuhide Tsuji, Hironori Matsuura, et al.
The Journal of Clinical Investigation|September 8, 2007
Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomasMirjana Urosevic, Kazuyasu Fujii, Bastien Calmels, et al.
Pageof 7